Cleo M. Salisbury

1.3k total citations
18 papers, 1.1k citations indexed

About

Cleo M. Salisbury is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Organic Chemistry. According to data from OpenAlex, Cleo M. Salisbury has authored 18 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 6 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Organic Chemistry. Recurrent topics in Cleo M. Salisbury's work include Monoclonal and Polyclonal Antibodies Research (6 papers), Click Chemistry and Applications (4 papers) and Advanced Biosensing Techniques and Applications (4 papers). Cleo M. Salisbury is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (6 papers), Click Chemistry and Applications (4 papers) and Advanced Biosensing Techniques and Applications (4 papers). Cleo M. Salisbury collaborates with scholars based in United States, Sweden and Switzerland. Cleo M. Salisbury's co-authors include Benjamin F. Cravatt, Jonathan A. Ellman, Dustin J. Maly, Dhaval N. Gosalia, Scott L. Diamond, Jonathan A. Ellman, Danielle L. Leiske, Sophie Allauzen, David Peretz and Michael D. Connolly and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and PLoS ONE.

In The Last Decade

Cleo M. Salisbury

18 papers receiving 1.1k citations

Peers

Cleo M. Salisbury
Yun Ge China
E. K. RYU South Korea
Chengzao Sun United States
Les P. Miranda United States
Daniel Gygax Switzerland
Yun Ge China
Cleo M. Salisbury
Citations per year, relative to Cleo M. Salisbury Cleo M. Salisbury (= 1×) peers Yun Ge

Countries citing papers authored by Cleo M. Salisbury

Since Specialization
Citations

This map shows the geographic impact of Cleo M. Salisbury's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cleo M. Salisbury with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cleo M. Salisbury more than expected).

Fields of papers citing papers by Cleo M. Salisbury

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cleo M. Salisbury. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cleo M. Salisbury. The network helps show where Cleo M. Salisbury may publish in the future.

Co-authorship network of co-authors of Cleo M. Salisbury

This figure shows the co-authorship network connecting the top 25 collaborators of Cleo M. Salisbury. A scholar is included among the top collaborators of Cleo M. Salisbury based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cleo M. Salisbury. Cleo M. Salisbury is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Salisbury, Cleo M., et al.. (2021). The pandemic and resilience for the future: AccBio 2021. Biotechnology Progress. 38(1). e3207–e3207. 10 indexed citations
2.
Izadi, Saeed, Jianping Yin, Christine Huang, et al.. (2019). Dissecting the molecular basis of high viscosity of monospecific and bispecific IgG antibodies. mAbs. 12(1). 1692764–1692764. 40 indexed citations
3.
Leiske, Danielle L., et al.. (2018). Mitigation of Oxidation in Therapeutic Antibody Formulations: a Biochemical Efficacy and Safety Evaluation of N-Acetyl-Tryptophan and L-Methionine. Pharmaceutical Research. 35(11). 222–222. 27 indexed citations
4.
Leiske, Danielle L., et al.. (2017). Characterization of N-Acetyl-Tryptophan Degradation in Protein Therapeutic Formulations. Journal of Pharmaceutical Sciences. 106(12). 3499–3506. 11 indexed citations
5.
Wang, Y. John, et al.. (2017). The Use of a 2,2'-Azobis (2-Amidinopropane) Dihydrochloride Stress Model as an Indicator of Oxidation Susceptibility for Monoclonal Antibodies. Journal of Pharmaceutical Sciences. 107(2). 550–558. 21 indexed citations
6.
Salisbury, Cleo M., et al.. (2013). Microfluidic barcode assay for antibody-based confirmatory diagnostics. Lab on a Chip. 13(19). 3910–3910. 8 indexed citations
7.
Yam, Alice, Xuemei Wang, Michael D. Connolly, et al.. (2011). A Universal Method for Detection of Amyloidogenic Misfolded Proteins. Biochemistry. 50(20). 4322–4329. 31 indexed citations
8.
Yam, Alice, Xuemei Wang, Cleo M. Salisbury, et al.. (2010). Aβ40 Oligomers Identified as a Potential Biomarker for the Diagnosis of Alzheimer's Disease. PLoS ONE. 5(12). e15725–e15725. 83 indexed citations
9.
Nakai, Ryuichiro, Cleo M. Salisbury, Hugh Rosen, & Benjamin F. Cravatt. (2008). Ranking the selectivity of PubChem screening hits by activity-based protein profiling: MMP13 as a case study. Bioorganic & Medicinal Chemistry. 17(3). 1101–1108. 18 indexed citations
10.
Salisbury, Cleo M. & Benjamin F. Cravatt. (2008). Optimization of Activity-Based Probes for Proteomic Profiling of Histone Deacetylase Complexes. Journal of the American Chemical Society. 130(7). 2184–2194. 109 indexed citations
11.
Salisbury, Cleo M. & Benjamin F. Cravatt. (2007). Activity-based probes for proteomic profiling of histone deacetylase complexes. Proceedings of the National Academy of Sciences. 104(4). 1171–1176. 209 indexed citations
12.
Liu, Gang L., Cleo M. Salisbury, Charles S. Craik, et al.. (2007). Peptide-Nanoparticle Hybrid SERS Probes for Optical Detection of Protease Activity. Journal of Nanoscience and Nanotechnology. 7(7). 2323–2330. 24 indexed citations
13.
Salisbury, Cleo M. & Benjamin F. Cravatt. (2007). Click Chemistry‐Led Advances in High Content Functional Proteomics. QSAR & Combinatorial Science. 26(11-12). 1229–1238. 46 indexed citations
14.
Gosalia, Dhaval N., William S. Denney, Cleo M. Salisbury, Jonathan A. Ellman, & Scott L. Diamond. (2006). Functional phenotyping of human plasma using a 361‐fluorogenic substrate biosensing microarray. Biotechnology and Bioengineering. 94(6). 1099–1110. 28 indexed citations
15.
Salisbury, Cleo M. & Jonathan A. Ellman. (2006). Rapid Identification of Potent Nonpeptidic Serine Protease Inhibitors. ChemBioChem. 7(7). 1034–1037. 19 indexed citations
16.
Gosalia, Dhaval N., Cleo M. Salisbury, Jonathan A. Ellman, & Scott L. Diamond. (2005). High Throughput Substrate Specificity Profiling of Serine and Cysteine Proteases Using Solution-phase Fluorogenic Peptide Microarrays. Molecular & Cellular Proteomics. 4(5). 626–636. 130 indexed citations
17.
Gosalia, Dhaval N., Cleo M. Salisbury, Dustin J. Maly, Jonathan A. Ellman, & Scott L. Diamond. (2005). Profiling serine protease substrate specificity with solution phase fluorogenic peptide microarrays. PROTEOMICS. 5(5). 1292–1298. 85 indexed citations
18.
Salisbury, Cleo M., Dustin J. Maly, & Jonathan A. Ellman. (2002). Peptide Microarrays for the Determination of Protease Substrate Specificity. Journal of the American Chemical Society. 124(50). 14868–14870. 212 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026